98%
921
2 minutes
20
Since its introduction in 2018, the Vesical Imaging Reporting and Data System (VI-RADS) has emerged as a standardized and reproducible framework for multiparametric MRI assessment of bladder cancer, with validated diagnostic accuracy in distinguishing muscle-invasive from non-muscle-invasive disease. Despite growing international interest, expert consensus, and the system's inclusion in most major guidelines, real-world clinical adoption of VI-RADS remains limited. This AJR Expert Panel Narrative Review explores the key barriers that hinder the implementation of VI-RADS into everyday workflows across diverse healthcare settings, including skepticism among referring clinicians, an inability (unlike cystoscopy-based staging) to perform simultaneous tumor resection, suboptimal posttreatment performance, and variability in image quality and reader experience. Additional logistical and economic factors, including restricted access outside of specialized centers and limited cost-effectiveness data, further impair widespread uptake. The article outlines strategic recommendations to address these challenges, including standardizing bladder MRI quality, incorporating structured educational initiatives, refining VI-RADS protocols for posttreatment settings, and fostering multidisciplinary collaboration. VI-RADS has the potential to become a cornerstone of bladder cancer management, but the validation and implementation of a bladder-MRI pathway will depend on continued refinement, acceptance, and alignment across clinical, technical, and guideline domains.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2214/AJR.25.33634 | DOI Listing |
Acad Radiol
September 2025
Department of Urology, the Second Affiliated Hospital of Kunming Medical University, Kunming, China (H.S., Q.W., S.F., H.W.). Electronic address:
Rationale And Objectives: This study systematically evaluates the diagnostic performance of artificial intelligence (AI)-driven and conventional radiomics models in detecting muscle-invasive bladder cancer (MIBC) through meta-analytical approaches. Furthermore, it investigates their potential synergistic value with the Vesical Imaging-Reporting and Data System (VI-RADS) and assesses clinical translation prospects.
Methods: This study adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
AJR Am J Roentgenol
September 2025
Department of Radiology, NYU Langone Health, New York, NY (H.A.V.).
Since its introduction in 2018, the Vesical Imaging Reporting and Data System (VI-RADS) has emerged as a standardized and reproducible framework for multiparametric MRI assessment of bladder cancer, with validated diagnostic accuracy in distinguishing muscle-invasive from non-muscle-invasive disease. Despite growing international interest, expert consensus, and the system's inclusion in most major guidelines, real-world clinical adoption of VI-RADS remains limited. This AJR Expert Panel Narrative Review explores the key barriers that hinder the implementation of VI-RADS into everyday workflows across diverse healthcare settings, including skepticism among referring clinicians, an inability (unlike cystoscopy-based staging) to perform simultaneous tumor resection, suboptimal posttreatment performance, and variability in image quality and reader experience.
View Article and Find Full Text PDFKorean J Radiol
September 2025
Department of Radiology, Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Objective: Plasmacytoid urothelial carcinoma (PUC) is a rare aggressive bladder cancer subtype with limited imaging data owing to its low incidence. This study aimed to report the characteristic features of PUC on multiparametric MRI (mpMRI).
Materials And Methods: We retrospectively analyzed 13 patients with histologically confirmed PUC who underwent preoperative mpMRI between January 2019 and August 2024.
Curr Oncol
July 2025
Department of Urology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan.
The Vesical Imaging Reporting and Data System (VI-RADS) is used to detect muscle-invasive bladder cancer, with emerging prognostic implications. Integrating imaging parameters with molecular biomarkers may improve risk stratification in bladder cancer. This study evaluated whether combining VI-RADS scores with serum cytokeratin fragment 19 (CYFRA 21-1) levels-a clinically relevant biomarker for bladder cancer-could improve overall survival (OS) prediction.
View Article and Find Full Text PDFJ Surg Case Rep
August 2025
University of Global Health Equity (UGHE), Butaro Campus, Butaro Sector, Burera District, Northern Province 7078, Rwanda.
Para-vesical internal hernias are rare but serious complications of abdominal surgeries and can present as small bowel obstruction (SBO). We report the case of a 30-year-old woman with a history of Cesarean delivery 9 years prior, who presented with crampy abdominal pain, bilious vomiting, and obstipation. Imaging revealed findings consistent with SBO.
View Article and Find Full Text PDF